Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,116 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| W. L. Gore & Associates, Inc. | $186.34 | 1 | $0 (2019) |
| Lantheus Medical Imaging, Inc. | $179.67 | 3 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $144.32 | 3 | $0 (2019) |
| PFIZER INC. | $130.69 | 3 | $0 (2017) |
| Medtronic, Inc. | $118.10 | 1 | $0 (2024) |
| Amgen Inc. | $97.38 | 1 | $0 (2023) |
| Medtronic Vascular, Inc. | $67.11 | 1 | $0 (2017) |
| Braemar Manufacturing, LLC | $25.48 | 1 | $0 (2017) |
| Chiesi USA, Inc. | $23.58 | 1 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $21.82 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $118.10 | 1 | Medtronic, Inc. ($118.10) |
| 2023 | $97.38 | 1 | Amgen Inc. ($97.38) |
| 2019 | $318.21 | 3 | W. L. Gore & Associates, Inc. ($186.34) |
| 2018 | $135.63 | 3 | Lantheus Medical Imaging, Inc. ($97.64) |
| 2017 | $446.49 | 16 | PFIZER INC. ($130.69) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/02/2024 | Medtronic, Inc. | ABRE (Device) | Food and Beverage | In-kind items and services | $118.10 | General |
| Category: Stents | ||||||
| 01/26/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $97.38 | General |
| Category: Cardiology | ||||||
| 07/01/2019 | W. L. Gore & Associates, Inc. | SEAMGUARD Bioabsorbable Staple Line Reinforcement (Device) | Food and Beverage | In-kind items and services | $186.34 | General |
| Category: Devices | ||||||
| 05/21/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $120.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/25/2019 | Terumo Medical Corporation | AZUR (Device), TR Band | Food and Beverage | Cash or cash equivalent | $11.36 | General |
| Category: Vascular Embolization | ||||||
| 06/21/2018 | Cardinal Health 200, LLC | Mozec NC PTCA Balloon (Device) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Cardiovascular | ||||||
| 06/14/2018 | Lantheus Medical Imaging, Inc. | Definity (Drug) | Food and Beverage | In-kind items and services | $97.64 | General |
| Category: Contrast Agent | ||||||
| 03/15/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/21/2017 | Medicure Pharma Inc. | Aggrastat (tirofiban HCl) (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Acute cardiovascular care | ||||||
| 11/04/2017 | Medtronic Vascular, Inc. | VenaSeal (Device) | Food and Beverage | In-kind items and services | $67.11 | General |
| Category: EndoVenous Therapies | ||||||
| 10/24/2017 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $23.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/15/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/14/2017 | Lantheus Medical Imaging, Inc. | Definity (Drug) | Food and Beverage | In-kind items and services | $65.52 | General |
| Category: Contrast Agent | ||||||
| 08/15/2017 | Actelion Pharmaceuticals US, Inc. | OPSUMIT MACITENTAN (Drug), VELETRI EPOPROSTENOL, VENTAVIS ILOPROST | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: CARDIOVASCULAR DISORDERS | ||||||
| 05/26/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/27/2017 | Lantheus Medical Imaging, Inc. | Definity (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Contrast Agent | ||||||
| 04/20/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/17/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $106.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/28/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/17/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.63 | General |
| Category: Cardiovascular | ||||||
| 02/03/2017 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Cardio-pulmonary | ||||||
| 01/25/2017 | Braemar Manufacturing, LLC | Cardiac Monitoring Suite (Device) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Cardiology | ||||||
| 01/18/2017 | Astellas Pharma US Inc | Lexiscan (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 27 | 27 | $4,482 | $1,925 |
| 2022 | 12 | 1,105 | 1,234 | $164,930 | $61,956 |
| 2021 | 12 | 1,066 | 1,200 | $148,634 | $58,170 |
| 2020 | 13 | 934 | 1,080 | $119,987 | $45,436 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 27 | $4,482 | $1,925 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 269 | 350 | $52,846 | $29,978 | 56.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 254 | 261 | $50,634 | $12,400 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 95 | 95 | $22,451 | $11,267 | 50.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 182 | 193 | $10,615 | $1,816 | 17.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $2,430 | $1,255 | 51.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 25 | 25 | $4,850 | $1,248 | 25.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 29 | 29 | $2,639 | $1,178 | 44.6% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2022 | 27 | 27 | $8,343 | $1,033 | 12.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 75 | 102 | $2,754 | $659.97 | 24.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2022 | 46 | 47 | $2,961 | $463.07 | 15.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 30 | 30 | $1,470 | $447.73 | 30.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Office | 2022 | 28 | 29 | $609.00 | $141.87 | 23.3% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2022 | 33 | 34 | $2,328 | $70.31 | 3.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 267 | 344 | $50,568 | $29,880 | 59.1% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 232 | 234 | $43,992 | $11,339 | 25.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 63 | 63 | $14,569 | $7,536 | 51.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 177 | 188 | $9,964 | $1,791 | 18.0% |
| 93350 | Ultrasound examination of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2021 | 30 | 30 | $9,000 | $1,452 | 16.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 23 | $2,300 | $1,297 | 56.4% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 25 | 25 | $4,700 | $1,203 | 25.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $2,304 | $1,175 | 51.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 125 | 161 | $4,186 | $906.40 | 21.7% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Office | 2021 | 65 | 66 | $4,026 | $670.11 | 16.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 11 | $1,089 | $609.60 | 56.0% |
About Dr. Fernando Munoz, M.D
Dr. Fernando Munoz, M.D is a Cardiovascular Disease healthcare provider based in Akron, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114906997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fernando Munoz, M.D has received a total of $1,116 in payments from pharmaceutical and medical device companies, with $118.10 received in 2024. These payments were reported across 24 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,116).
As a Medicare-enrolled provider, Munoz has provided services to 3,132 Medicare beneficiaries, totaling 3,541 services with total Medicare billing of $167,488. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Akron, OH
- Active Since 01/11/2006
- Last Updated 02/26/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1114906997
Products in Payments
- SEAMGUARD Bioabsorbable Staple Line Reinforcement (Device) $186.34
- Definity (Drug) $179.67
- XARELTO (Drug) $144.32
- ELIQUIS (Drug) $128.11
- ABRE (Device) $118.10
- Repatha (Biological) $97.38
- VenaSeal (Device) $67.11
- Cardiac Monitoring Suite (Device) $25.48
- KENGREAL (Drug) $23.58
- OPSUMIT MACITENTAN (Drug) $21.82
- ENTRESTO (Drug) $21.63
- Lexiscan (Drug) $19.07
- Mozec NC PTCA Balloon (Device) $16.36
- Adempas (Drug) $15.10
- Aggrastat (tirofiban HCl) (Drug) $14.67
- CHANTIX (Drug) $13.21
- PRALUENT (Drug) $12.50
- AZUR (Device) $11.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Akron
Joseph Pietrolungo, Do Fsvmb Facc, DO FSVMB FACC
Cardiovascular Disease — Payments: $164,248
Vinayak Hegde, Md, MD
Cardiovascular Disease — Payments: $131,332
Maher Bazzi, Md, MD
Cardiovascular Disease — Payments: $28,783
Dr. Kevin Silver, Md,Facc,Fscai,Fasnc, MD,FACC,FSCAI,FASNC
Cardiovascular Disease — Payments: $16,467
Anmar Kanaa'n, Md, MD
Cardiovascular Disease — Payments: $13,540
Jonathan Buggey, Md, MD
Cardiovascular Disease — Payments: $5,987